Followers | 515 |
Posts | 38725 |
Boards Moderated | 5 |
Alias Born | 04/26/2012 |
![](https://investorshub.advfn.com/uicon/339224.png?cb=1580513498)
Sunday, October 07, 2018 11:26:36 AM
Market’s first large panel monitoring test for ovarian cancer
Use an elective screen for women seeking greater wellness
Screen women at elevated risk for ovarian cancer
High sensitivity and specificity for all types and stages of ovarian cancer
Research studies based on the screening of 257 total samples
79.7% combined sensitivity based on 55 of 69 OVC samples scored as positive
Specificity determined by screening 178 samples from healthy patients and 10 samples from patients with benign gynecological conditions
100% specificity based on 188 of 188 non-OVC samples scored as negative
Identifies stage I, II, III and IV disease markers in patient samples
Detects stage IA disease markers with ~80% sensitivity
Detects borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma in patient sera
Multi-plexed microarray assay reads approximately 100 proteomic biomarkers
Proteomic panel provides definitive real-time test results
Microarray format reduces serum requirement to 0.1-0.25 ml per sample run
Blood cards can be used for sample collection
Fluorescence detection ensures high signal detectivity
Test controls eliminate experimental false positives and false negatives
High-throughput format scales to any number of patient samples
Automated process permits large-scale (e.g. 1,000,000 sample+) screening
Supplement OVA1® and other multi-analyte tests
Supplement single marker tests including cancer antigen 125 (CA-125) and human epididymis protein (HE4)
Supplement genetic tests including BRCA1 and BRCA2
Supplement imaging techniques including transvaginal ultrasound, computerized tomography (CT) scans, and x-rays
Screen patient sera from breast, cervical, uterine and other cancer patients
Test samples from patients with ovarian cysts and other benign conditions
:)
All my posts are my opinion only. Please do your due diligence on all your investments.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM